School of Medicine
Showing 101-110 of 245 Results
-
Nathan Reticker-Flynn, PhD
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsTo metastasize throughout our bodies, tumors subvert and co-opt our immune systems. Our lab seeks to uncover how these processes occur and develops therapies to put a stop to them.
-
Andrew Rezvani, M.D.
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsClinical research in allogeneic hematopoietic cell transplantation
-
James H Rhee
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Rhee is a physiatrist and a clinical assistant professor of physical medicine and rehabilitation. For patients with spine and musculoskeletal conditions, he focuses on providing exceptional care emphasizing minimally invasive solutions designed to optimize symptom managementand patient function.
Building on his background in engineering and on his specialized medical training and experience, Dr. Rhee welcomes opportunities to combine medical, mechanical, and interpersonal approaches to the diagnosis and treatment of each patient. He offers a full range of treatment modalities, including epidural steroid injection procedures, sacroiliac and facet joint injections, trigger point and soft tissue injections, orthopedic joint injections, and more. He also provides medial branch blocks and radiofrequency ablations, and performs electrodiagnostic studies.
Among the wide range of conditions that Dr. Rhee treats are bursitis, herniated discs, radiculopathy, sciatica, spinal stenosis, spondylolisthesis, and spondylosis. He also has treated many forms of joint and muscle pain: facet joint, back, neck, hip, and sacroiliac joint pain.
Dr. Rhee’s experience encompasses short-term and long-term care for both acute and chronic conditions, including musculoskeletal injuries, spinal problems, mixed spine-neck and spine-shoulder disorders, and peripheral damage. Many of the cases he treats are injury-related, while a significant number of others are associated with aging. Another portion of his patient population presents with conditions stemming from developmental anomalies.
Prior to joining Stanford Health Care, Dr. Rhee was in private practice in the Bay Area. Previously, he also served in the US Army as a troop medical clinic officer-in-charge and as a brigade surgeon.
Dr. Rhee is board certified by the American Board of Physical Medicine and Rehabilitation. He is a fellow of the American Academy of Physical Medicine and Rehabilitation and a member of the American Society of Interventional Pain Physicians, North American Spine Society, and Spine Intervention Society. -
William Rhine
Professor of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsNeonatology, extracorporeal membrane oxygenation, nitric oxide therapy, mechanisms of bilirubin toxicity and brain injury, non-invasive biotechnologies to study cellular and organ metabolism.
-
Fauzia Riaz, MD, MHS
Assistant Professor of Medicine (Oncology)
BioDr. Riaz is dedicated to advancing breast cancer treatment through an innovative clinical trial program that focuses on cutting-edge therapeutics and biomarkers.
Dr. Riaz is studying circulating tumor (ct)DNA-minimal residual disease (MRD) as a pivotal biomarker for early-stage breast cancer. She aims to enhance its use in surveillance and early detection while guiding personalized treatment strategies through novel clinical trials. Furthermore, she is committed to improving immunotherapy efficacy by modifying the tumor microenvironment. Her research involves developing early-phase trials that integrate novel therapeutic approaches, combining immunotherapy and radiotherapy. As a Clinical Assistant Professor at Stanford University School of Medicine, Dr. Riaz is also committed to improving the accessibility of cutting edge therapies to all patients. She is leading a collaborative effort with multiple institutions to develop databases that track patient outcomes and inform treatment practices.
Dr. Riaz’s overarching goal is to expand early-phase clinical trials and foster academic-industry partnerships to advance the field of breast oncology and improve patient care.
